Actively Recruiting

Age: 18Years +
FEMALE
ID06801756

Description of Pregnancies and Their Impact on Craniopharyngioma in Women

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-04-02

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Craniopharyngiomas are rare, benign tumors that develop near the pituitary gland and mostly affect children, adolescents, and adults. These tumors can cause serious health issues due to their invasive nature and tendency to recur, impacting quality of life through hormonal, vision, and cognitive problems. There is limited information about pregnancy outcomes and effects on craniopharyngiomas in women who have had these tumors, which this study aims to explore. This research involves patients who have or had craniopharyngiomas and focuses on describing pregnancies and their impact on tumor behavior. Participants will complete questionnaires about their parental projects, pregnancy complications, and the tumor's response during and after pregnancy. The study is observational and conducted at a specialized center with expertise in endocrine and reproductive health. Participants will provide information through questionnaires supplemented by medical records. Researchers will assess how pregnancies were achieved, hormonal treatment adjustments, tumor changes, visual and neurocognitive effects, and weight changes during pregnancy. The study will last about one year, with each participant's involvement around thirty minutes. Outcomes will help understand pregnancy's role in craniopharyngioma management and patient care.

CONDITIONS

Brief Title

Craniopharyngioma and Pregnancies

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged at least 18 years old
  • Patients with or having had a craniopharyngioma
  • Patients informed and not opposed to participation in research
Not Eligible

You will not qualify if you...

  • Patients who don't speak French
  • Patients without medical care insurance
  • Patients under legal protection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Monitoring

Duration - Up to 12 months

Participants complete questionnaires about their pregnancy history, complications, and the impact of pregnancy on craniopharyngioma. Medical records are reviewed to supplement questionnaire data.

1 telephone contact to complete questionnaire

Trial Site Locations

Total: 1 location

1

Pitié-Salpêtrière hospital

Paris, France, 75013

Actively Recruiting

Loading map...

Research Team

A

Anne BACHELOT, MD, PhD

Z

Zeina Chakhtoura, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Phentermine/Topiramate in Children, Adolescents, and Young A...

Hypothalamic Obesity

Actively Recruiting

2 locations

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop...

Craniopharyngioma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here